The balance between cell cycle arrest and cell proliferation: Control by the extracellular matrix and by contact inhibition

Interface Focus

Volumn 4, Issue 3, 2014, Pages

  Gérard, Claude ^a,c   Goldbeter, Albert ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c DE DUVE INSTITUTE   (Belgium)

Author keywords

Cell cycle; Contact inhibition; Cyclin dependent kinase oscillations; Extracellular matrix; Focal adhesion kinase; Systems biology

Indexed keywords

EID: 84899441649     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2013.0075     Document Type: Article

References (74)

1. Morgan DO. 1995 Principles of CDK regulation. Nature 374, 131-134.(doi:10.1038/374131a0)
2. Stern B, Nurse P. 1996 A quantitative model for the cdc2 control of S phase and mitosis in fission yeast. Trends Genet. 12, 345-350.(doi:10.1016/0168-9525(96)10036-6)
3. Coudreuse D, Nurse P. 2010 Driving the cell cycle with a minimal CDK control network. Nature 468, 1074-1079.(doi:10.1038/nature09543)
4. Morgan DO. 2007 The cell cycle: principles of control. London, UK: New Science Press Ltd in association with Oxford University Press.
5. Santamaria D et al. 2007 Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448, 811-815.(doi:10.1038/nature06046)
6. Tyson JJ. 1991 Modeling the cell division cycle: cdc2 and cyclin interactions. Proc. Natl Acad. Sci. USA 88, 7328-7332.(doi:10.1073/pnas.88.16.7328)
7. Goldbeter A. 1991 A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase. Proc. Natl Acad. Sci. USA 88, 9107-9111.(doi:10. 1073/pnas.88.20.9107)
8. Novak B, Tyson JJ. 1993 Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J. Cell Sci. 106, 1153-1168.
9. Chen KC, Calzone L, Csikasz-Nagy A, Cross FR, Novak B, Tyson JJ. 2004 Integrative analysis of cell cycle control in budding yeast. Mol. Biol. Cell 15, 3841-3862.(doi:10.1091/mbc.E03-11-0794)
10. Novak B, Tyson JJ. 1997 Modeling the control of DNA replication in fission yeast. Proc. Natl Acad. Sci. USA 94, 9147-9152.(doi:10.1073/pnas. 94.17.9147)
11. Gerard C, Goldbeter A. 2009 Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle. Proc. Natl Acad. Sci. USA 106, 21643-21648.(doi:10.1073/pnas. 0903827106)
12. Qu Z, Weiss JN, MacLellan WR. 2003 Regulation of the mammalian cell cycle: a model of the G1-to-S transition. Am. J. Physiol. Cell Physiol. 284, C349-C364.(doi:10.1152/ajpcell.00066.2002)
13. Swat M, Kel A, Herzel H. 2004 Bifurcation analysis of the regulatory modules of the mammalian G1/S transition. Bioinformatics 20, 1506-1511.(doi:10. 1093/bioinformatics/bth110)
14. Haberichter T et al. 2007 A systems biology dynamical model of mammalian G1 cell cycle progression. Mol. Syst. Biol. 3, 84.(doi:10.1038/ msb4100126)
15. Alfieri R, Barberis M, Chiaradonna F, Gaglio D, Milanesi L, Vanoni M, Klipp E, Alberghina L. 2009 Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation. BMC Bioinform. 10(Suppl. 12), S16.(doi:10.1186/1471-2105-10-S12-S16)
16. Novak B, Tyson JJ. 2004 A model for restriction point control of the mammalian cell cycle. J. Theor. Biol. 230, 563-579.(doi:10.1016/j.jtbi.2004.04.039)
17. He E, Kapuy O, Oliveira RA, Uhlmann F, Tyson JJ, Novak B. 2011 System-level feedbacks make the anaphase switch irreversible. Proc. Natl Acad. Sci. USA 108, 10016-10021.(doi:10.1073/pnas. 1102106108)
18. Gerard C, Goldbeter A. 2012 From quiescence to proliferation: Cdk oscillations drive the mammalian cell cycle. Front. Physiol. 3, 413.(doi:10.3389/fphys. 2012.00413)
19. Gerard C, Goldbeter A. 2011 A skeleton model for the network of cyclin-dependent kinases driving the mammalian cell cycle. Interface Focus 1, 24-35.(doi:10.1098/rsfs.2010.0008)
20. Gerard C, Gonze D, Goldbeter A. 2012 Effect of positive feedback loops on the robustness of oscillations in the network of cyclin-dependent kinases driving the mammalian cell cycle. FEBS J. 279, 3411-3431.(doi:10.1111/j.1742-4658.2012.08585.x)
21. Reiske HR, Zhao J, Han DC, Cooper LA, Guan JL. 2000 Analysis of FAK-associated signaling pathways in the regulation of cell cycle progression. FEBS Lett. 486, 275-280.(doi:10.1016/S0014-5793(00) 02295-X)
22. Zeng Q, Hong W. 2008 The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 13, 188-192.(doi:10.1016/j.ccr.2008.02.011)
23. Tyson JJ, Novak B. 2001 Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. J. Theor. Biol. 210, 249-263.(doi:10.1006/jtbi.2001.2293)
24. Novak B, Tyson JJ, Gyorffy B, Csikasz-Nagy A. 2007 Irreversible cell-cycle transitions are due to systems-level feedback. Nat. Cell Biol. 9, 724-728.(doi:10. 1038/ncb0707-724)
25. Domingo-Sananes MR, Kapuy O, Hunt T, Novak B. 2011 Switches and latches: a biochemical tug-of-war between the kinases and phosphatases that control mitosis. Phil. Trans. R. Soc. B 366, 3584-3594.(doi:10.1098/rstb.2011.0087)
26. Gonze D, Hafner M. 2010 Positive feedbacks contribute to the robustness of the cell cycle with respect to molecular noise. In Advances in the theory of control, signals and systems with physical modeling (eds J Lévine, P Müllhaupt). Lecture Notes in Control and Information Sciences, no. 407, pp. 283-295. Berlin, Germany: Springer.(doi:10.1007/978-3-642-16135-3_23)
27. Hanahan D, Weinberg RA. 2011 Hallmarks of cancer: the next generation. Cell 144, 646-674.(doi:10.1016/j.cell.2011.02.013)
28. Goldbeter A. 1996 Biochemical oscillations and cellular rhythms: the molecular bases of periodic and chaotic behaviour. Cambridge, UK: Cambridge University Press.
29. Alao JP. 2007 The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 6, 24.(doi:10.1186/1476-4598-6-24)
30. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L. 2000 Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 60, 4000-4004.
31. Yasmeen A, Berdel WE, Serve H, Muller-Tidow C. 2003 E-and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Rev. Mol. Diagn. 3, 617-633.(doi:10.1586/14737159.3.5.617)
32. Gala S, Marreiros A, Stewart GJ, Williamson P. 2001 Overexpression of E2F-1 leads to cytokine-independent proliferation and survival in the hematopoietic cell line BaF-B03. Blood 97, 227-234.(doi:10.1182/blood.V97.1.227)
33. Ray D, Kiyokawa H. 2008 CDC25A phosphatase: a rate-limiting oncogene that determines genomic stability. Cancer Res. 68, 1251-1253.(doi:10.1158/ 0008-5472.CAN-07-5983)
34. Hinds PW. 1995 The retinoblastoma tumor suppressor protein. Curr. Opin. Genet. Dev. 5, 79-83.(doi:10.1016/S0959-437X(95)90057-8)
35. Gu J et al. 2013 A role for p21-activated kinase 7 in the development of gastric cancer. FEBS J. 280, 46-55.(doi:10.1111/febs.12048)
36. Garcia-Higuera I, Manchado E, Dubus P, Canamero M, Mendez J, Moreno S, Malumbres M. 2008 Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat. Cell Biol. 10, 802-811.(doi:10.1038/ncb1742)
37. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H. 2004 The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann. Oncol. 15, 252-256.(doi:10.1093/annonc/mdh073)
38. Cristofalo VJ, Pignolo RJ. 1993 Replicative senescence of human fibroblast-like cells in culture. Physiol. Rev. 73, 617-638.
39. Green DR. 2011 Means to an end: apoptosis and other cell death mechanisms. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
40. Castedo M, Perfettini J-L, Roumier T, Kroemer G. 2002 Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Diff. 9, 1287-1293.(doi:10.1038/sj.cdd.4401130)
41. Huang S, Ingber DE. 1999 The structural and mechanical complexity of cell-growth control. Nat. Cell Biol. 1, E131-E138.(doi:10.1038/13043)
42. Giancotti FG, Ruoslahti E. 1999 Integrin signaling. Science 285, 1028-1032.(doi:10.1126/science.285. 5430.1028)
43. Mitra SK, Schlaepfer DD. 2006 Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18, 516-523.(doi:10.1016/j.ceb. 2006.08.011)
44. Assoian RK, Klein EA. 2008 Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol. 18, 347-352.(doi:10.1016/j.tcb.2008.05.002)
45. Pugacheva EN, Roegiers F, Golemis EA. 2006 Interdependence of cell attachment and cell cycle signaling. Curr. Opin. Cell Biol. 18, 507-515.(doi:10.1016/j.ceb.2006.08.014)
46. Mitra SK, Hanson DA, Schlaepfer DD. 2005 Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6, 56-68.(doi:10. 1038/nrm1549)
47. Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. 2000 Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 19, 2056-2068.(doi:10. 1093/emboj/19.9.2056)
48. Assoian RK. 1997 Control of the G1 phase cyclin-dependent kinases by mitogenic growth factors and the extracellular matrix. Cytokine Growth Factor Rev. 8, 165-170.(doi:10.1016/S1359-6101(97)00011-7)
49. Huang S, Chen CS, Ingber DE. 1998 Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol. Biol. Cell 9, 3179-3193.(doi:10.1091/mbc.9.11.3179)
50. Assoian RK, Schwartz MA. 2001 Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr. Opin. Genet. Dev. 11, 48-53.(doi:10.1016/ S0959-437X(00)00155-6)
51. Zhao J, Pestell R, Guan JL. 2001 Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol. Biol. Cell 12, 4066-4077.(doi:10.1091/mbc.12.12.4066)
52. Zhao J, Guan JL. 2009 Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 28, 35-49.(doi:10.1007/s10555-008-9165-4)
53. Bryant P, Zheng Q, Pumiglia K. 2006 Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/ Cip1 through Skp2-dependent and -independent mechanisms. Mol. Cell Biol. 26, 4201-4213.(doi:10.1128/MCB.01612-05)
54. Strupack DG, Cheresh DA. 2002 Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 115, 3729-3738.(doi:10.1242/jcs.00071)
55. Schwartz MA. 1997 Integrins, oncogenes, and anchorage independence. J. Cell Biol. 139, 575-578.(doi:10.1083/jcb.139.3.575)
56. Ward KK et al. 2013 Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression. Clin. Exp. Metastasis 30, 579-594.(doi:10.1007/s10585-012-9562-5)
57. Cao Z, Zhang R, Li J, Huang H, Zhang D, Zhang J, Gao J, Chen J, Huang C. 2013 XIAP regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/C-Jun axis. J. Biol. Chem. 288, 20238-20247.(doi:10.1074/jbc.M112. 448365)
58. Yang XH, Sladek TL. 1995 Overexpression of the E2F-1 transcription factor gene mediates cell transformation. Gene Expr. 4, 195-204.
59. Enderle L, McNeill H. 2013 Hippo gains weight: added insights and complexity to pathway control. Sci. Signal. 6, er7.(doi:10.1126/scisignal. 6301er7)
60. Harvey KF, Zhang X, Thomas DM. 2013 The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257.(doi:10.1038/nrc3458)
61. Saucedo LJ, Edgar BA. 2007 Filling out the Hippo pathway. Nat. Rev. Mol. Cell Biol. 8, 613-621.(doi:10.1038/nrm2221)
62. Fan R, Kim NG, Gumbiner BM. 2013 Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proc. Natl Acad. Sci. USA 110, 2569-2574.(doi:10.1073/pnas. 1216462110)
63. Tilghman RW, Parsons JT. 2008 Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin. Cancer Biol. 18, 45-52.(doi:10.1016/j.semcancer.2007.08.002)
64. Brunton VG, Frame MC. 2008 Src and focal adhesion kinase as therapeutic targets in cancer. Curr. Opin. Pharmacol. 8, 427-432.(doi:10.1016/j.coph.2008. 06.012)
65. Guan JL, Shalloway D. 1992 Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358, 690-692.(doi:10. 1038/358690a0)
66. Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo FD, Grgory RI. 2014 Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 156, 893-906.(doi:10.1016/j.cell.2013.12.043)
67. Coussens LM, Werb Z. 2002 Inflammation and cancer. Nature 420, 860-867.(doi:10.1038/ nature01322)
68. Iliopoulos D, Hirsch HA, Struhl K. 2009 An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706.(doi:10.1016/j. cell.2009.10.014)
69. Sonnenschein C, Soto AM. 2008 Theories of carcinogenesis: an emerging perspective. Semin. Cancer Biol. 18, 372-377.(doi:10.1016/j. semcancer.2008.03.012)
70. Spencer SL, Cappell SD, Tsai F-C, Overton KW, Wang CL, Myer T. 2013 The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell 155, 369-383.(doi:10. 1016/j.cell.2013.08.062)
71. Zhang T. 2013 Phase portraits of the proliferation-quiescence decision. Sci. Signal. 6, pe 37.(doi:10. 1126/scisignal.2004891)
72. Bueno MJ, Pérez de Castro I, Malumbres M. 2008 Control of cell proliferation pathways by microRNAs. Cell Cycle 7, 3143-3148.(doi:10.4161/ cc.7.20.6833)
73. Bueno MJ, Malumbres M. 2011 MicroRNAs and the cell cycle. Biochim. Biophys. Acta 1812, 592-601.(doi:10.1016/j.bbadis.2011.02.002)
74. Eser P, Demal C, Maier KC, Schwalb B, Pirkl N, Martin DE, Cramer P, Tresch A. 2014 Periodic mRNA synthesis and degradation co-operate during cell cycle gene expression. Mol. Syst. Biol. 10, 717.(doi:10.1002/msb.134886)